Editor's Corner | DAPT, Our Genome and Clopidogrel "Resistance": Are We Near an Answer to "Which Drug, When?" - American College of Cardiology
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial - The Lancet
Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health - ScienceDirect
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan | Scientific Reports
Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram
SOLACI | Latin American Society of Interventional Cardiology
Frontiers | Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | Circulation
Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study | Stroke: Vascular and Interventional Neurology
How to Switch from Clopidogrel to Prasugrel or Ticagrelor - ppt download
How to Switch from Clopidogrel to Prasugrel or Ticagrelor - ppt download
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptorâ•fiInhibiting Therapies
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ
Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI | SpringerLink
Switching between oral... - البورد العراقي للصيدلة السريرية | Facebook
Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram
Fernando de la Guía on X: "Algorithm for switching between oral P2Y12 inhibitors In the acute and chronic setting #ESCCongress @escardio https://t.co/JWK126ejsx" / X
When to Switch and How to Switch - ppt download
Should You Switch the DAPT Agent a Month After ACS? | Clinician Reviews
mandeep singh on X: "Switching P2Y12 after PCI: 1. Wait 24h except Clopidogrel (C) to ticagrelor (T)/Prasugrel (P). 2. Give loading dose <30d and maintenance dose after except T to P/C switch:
Clopidogrel and ticagrelor co-therapy resulted in more patients... | Download Scientific Diagram
Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark - The Lancet Regional Health – Europe
Dr. Sheila Sahni on X: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC
Escalating P2Y 12 inhibiting therapy (switching from clopidogrel to... | Download Scientific Diagram
